Additionally, the critical role of RUNX2 in suppressing osteoblast maturation to support the expansion of an immature osteoblast population in FD identifies RUNX2 as a probable candidate for FD diagnosis and a treatment target [68]. The gene discussed is RUNX2; the disease is Fabry disease.